(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA COMBINADA DE RADIOIMUNOCONJUGADOS E INIBIDORES DE CHECKPOINT

Em AnáliseInvention PatentPCT · US2022033058

Application data

Invention Patent TERAPIA COMBINADA DE RADIOIMUNOCONJUGADOS E INIBIDORES DE CHECKPOINT de FUSION PHARMACEUTICALS INC. — IPC A61K 51/00
Invention Patent TERAPIA COMBINADA DE RADIOIMUNOCONJUGADOS E INIBIDORES DE CHECKPOINT de FUSION PHARMACEUTICALS INC. — IPC A61K 51/00. Drawing published by the INPI in the Industrial Property Gazette.

Number

112023026076

Type

Invention Patent

Filing

06/10/2022

Publication

03/05/2024

PCT

US2022033058

Progress at the INPI

  1. Filing06/10/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 06/10/2022. It awaits formal examination and publication in the RPI gazette.

AlertaMarcas

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/05/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

FUSION PHARMACEUTICALS INC.

CA

See this company's full portfolio

Inventors

E. B. (pessoa física)

CA

J. V. (pessoa física)

CA

J. M. (pessoa física)

CA

M. H. (pessoa física)

CA

N. G. (pessoa física)

US

Technical data

Priority claims

US

63/209,736 · 06/11/2021

Abstract

TERAPIA COMBINADA DE RADIOIMUNOCONJUGADOS E INIBIDORES DE CHECKPOINT. Terapias combinadas compreendendo a administração de radioimunoconjugados e um ou mais inibidores de checkpoint.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

03/05/2024

RPI 2774

Alteração de dados cadastrais

#1.1

12/19/2023

RPI 2763

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.